Turkish Version of the Movement Imagery Questionnaire-3

April 22, 2017 updated by: Burcu Dilek, Hacettepe University

Reliability and Validity of the Turkish Version of the Movement Imagery Questionnaire-3

Motor imagery is the mental representation of movement without any body movement. According to recent studies motor imagery contains three strategies to mentally simulate the movements: internal visual, external visual and kinesthetic imagery. Motor imagery is associated with cortical reorganization and functional improvements and it does not only related with motor performance, it also influces cognitions. Movement Imagery Questionnaire-3 (MIQ-3) is the recent, modified version of the Movement Imagery Questionnaire-Revised, Second Edition and measures imagery ability in terms of ease of imagery.

The aim of this study is to translate MIQ-3 into Turkish and evaluate its test-retest reliability for Turkish-speaking population.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

185

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Istanbul Medipol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers

Description

Inclusion Criteria:

  • age above 18, consenting, with no limitation in mobility or movement disorder

Exclusion Criteria:

  • refuse to attend to the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cronbach's Alpha coefficient
Time Frame: 2 years
Cronbach's Alpha coefficient was used to determine internal consistency of the questionnaire and its subscales
2 years
MIQ-3 total score
Time Frame: 2 years
MIQ-3 total score was got after calculate the all values.
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MIQ-3 subscale score
Time Frame: 2 years
MIQ-3 subscore was got after calculate the all values for each subscale.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

January 1, 2017

Study Registration Dates

First Submitted

April 16, 2017

First Submitted That Met QC Criteria

April 22, 2017

First Posted (Actual)

April 26, 2017

Study Record Updates

Last Update Posted (Actual)

April 26, 2017

Last Update Submitted That Met QC Criteria

April 22, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • GO 14/569

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Image, Body

Clinical Trials on Determining Imaginary levels

Subscribe